Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma.

Trial Profile

Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2014

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Nov 2014 Status changed from active,no longer recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
    • 18 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top